Lynette Smith Selected Research

Lynette Smith Research Topics

Disease

18	Neoplasms (Cancer) 01/2022 - 01/2006
3	Adenocarcinoma 01/2022 - 06/2019
3	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022 - 02/2010
3	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2016
3	Infections 01/2019 - 03/2012
3	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 12/2014 - 02/2010
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2013 - 12/2007
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 06/2019
2	Peritoneal Neoplasms 01/2018 - 12/2016
2	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 12/2016
2	Mucositis 01/2017 - 11/2014
2	Lymphoma (Lymphomas) 05/2014 - 02/2010
2	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 05/2014 - 02/2010
2	Pain (Aches) 01/2012 - 01/2006
2	Postoperative Hemorrhage 03/2006 - 01/2006
1	Pancreatitis 12/2021
1	Leukoplakia 10/2021
1	Squamous Cell Carcinoma of Head and Neck 10/2021
1	Carcinoma (Carcinomatosis) 06/2021
1	Esophageal Neoplasms (Esophageal Cancer) 06/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Neuroblastoma 11/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2019
1	Brain Neoplasms (Brain Tumor) 03/2018
1	Chronic Renal Insufficiency 01/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2017
1	Xerostomia 01/2017
1	Oropharyngeal Neoplasms 01/2017
1	Weight Loss (Weight Reduction) 01/2017
1	Ovarian Epithelial Carcinoma 12/2016
1	Carcinogenesis 01/2016
1	Oligodendroglioma 10/2015
1	Central Nervous System Diseases (CNS Diseases) 08/2015
1	Residual Neoplasm 08/2015
1	Neutropenia 12/2014
1	Burkitt Lymphoma (Burkitt's Lymphoma) 11/2014
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 05/2014
1	Extranodal NK-T-Cell Lymphoma 05/2014
1	Chronic Obstructive Pulmonary Disease (COPD) 03/2014
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2013
1	B-Cell Lymphoma (Lymphoma, B Cell) 09/2013
1	Necrosis 06/2013

Drug/Important Bio-Agent (IBA)

5	Rituximab (Mabthera)FDA Link 08/2015 - 01/2011
2	Biological ProductsIBA 12/2021 - 05/2014
2	Hormones (Hormone)IBA 01/2021 - 01/2008
2	Anaplastic Lymphoma KinaseIBA 05/2014 - 02/2010
2	Hemoglobins (Hemoglobin)IBA 03/2006 - 01/2006
2	Narcotics (Narcotic Analgesics)IBA 03/2006 - 01/2006
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	DNA Methyltransferase 3AIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 12/2021
1	MucinsIBA 12/2021
1	palbociclibIBA 10/2021
1	Cyclin D1IBA 10/2021
1	AfatinibIBA 10/2021
1	Coloring Agents (Dyes)IBA 05/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Chemotactic FactorsIBA 11/2020
1	BuffersIBA 11/2020
1	LigandsIBA 11/2020
1	AlginatesIBA 11/2020
1	CytokinesIBA 11/2020
1	ChemokinesIBA 11/2020
1	Insulin (Novolin)FDA Link 01/2019
1	AnticoagulantsIBA 03/2018
1	taxaneIBA 12/2016
1	PlatinumIBA 12/2016
1	CyclinsIBA 01/2016
1	Lomustine (CCNU)FDA Link 10/2015
1	Vincristine (Oncovin)FDA LinkGeneric 10/2015
1	Procarbazine (Matulane)FDA Link 10/2015
1	Vinblastine (Vinblastine Sulfate)FDA Link 12/2014
1	MicroRNAs (MicroRNA)IBA 03/2014
1	GelsIBA 03/2014
1	CollagenIBA 03/2014
1	Fibronectins (Fibronectin)IBA 03/2014
1	AntibodiesIBA 10/2013

Therapy/Procedure

9	Therapeutics 01/2021 - 10/2007
5	Drug Therapy (Chemotherapy) 01/2017 - 06/2013
3	Cytoreduction Surgical Procedures 01/2019 - 12/2016
3	Hyperthermic Intraperitoneal Chemotherapy 01/2019 - 12/2016
2	Radiotherapy 01/2022 - 06/2013
2	Pancreatectomy 01/2018 - 12/2009
2	Chemoradiotherapy 10/2017 - 01/2017
2	Combination Drug Therapy (Combination Chemotherapy) 12/2016 - 10/2013
2	Operative Time 03/2006 - 01/2006
1	Neoadjuvant Therapy 06/2021
1	Immunotherapy 11/2020
1	Precision Medicine 01/2020
1	Pancreaticoduodenectomy 06/2019
1	Esophagectomy 01/2019
1	Hepatectomy 01/2019
1	Enteral Nutrition (Feeding, Tube) 01/2017
1	Gastrostomy 01/2017
1	Drug Tapering 12/2014